Skip to main content

. 1959 Jun;38(6):873–881. doi: 10.1172/JCI103869

A BIOCHEMICAL STUDY OF CERTAIN SKELETAL MUSCLE CONSTITUENTS IN HUMAN PROGRESSIVE MUSCULAR DYSTROPHY^{^*}

Paul J Vignos Jr ¹, M Lefkowitz ¹

PMCID: PMC293236 PMID: 13654523

873

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

ANDRES R., CADER G., ZIERLER K. L. Metabolic exchange of human muscle in situ. Am J Phys Med. 1955 Feb;34(1):286–290. [PubMed] [Google Scholar]
BARNES B. A., GORDON E. B., COPE O. Skeletal muscle analyses in health and in certain metabolic disorders. I. The method of analysis and the values in normal muscle. J Clin Invest. 1957 Aug;36(8):1239–1248. doi: 10.1172/JCI103521. [DOI] [PMC free article] [PubMed] [Google Scholar]
CANTONI G. L., VIGNOS P. J., Jr Enzymatic mechanism of creatine synthesis. J Biol Chem. 1954 Aug;209(2):647–659. [PubMed] [Google Scholar]
DREYFUS J. C., SCHAPIRA G., SCHAPIRA F. Biochemical study of muscle in progressive muscular dystrophy. J Clin Invest. 1954 May;33(5):794–797. doi: 10.1172/JCI102950. [DOI] [PMC free article] [PubMed] [Google Scholar]
FENN W. O. Recent advances in basic muscle chemistry, physiology, and pharmacology; introductory remarks. Am J Phys Med. 1955 Feb;34(1):8–10. [PubMed] [Google Scholar]
FOLCH J., ASCOLI I., LEES M., MEATH J. A., LeBARON N. Preparation of lipide extracts from brain tissue. J Biol Chem. 1951 Aug;191(2):833–841. [PubMed] [Google Scholar]
GONNELLA C., HARMON G., JACOBS M. The role of the physical therapist in the gamma globulin poliomyelitis prevention study. Phys Ther Rev. 1953 Jul;33(7):337–345. doi: 10.1093/ptj/33.7.337. [DOI] [PubMed] [Google Scholar]
HASSELBACH W., SCHNEIDER G. Der L-Myosin- und Aktingehalt des Kaninchenmuskels. Biochem Z. 1951;321(6):462–475. [PubMed] [Google Scholar]
Michelson A. M., Russell E. S., Harman P. J. Dystrophia Muscularis: A HEREDITARY PRIMARY MYOPATHY IN THE HOUSE MOUSE. Proc Natl Acad Sci U S A. 1955 Dec 15;41(12):1079–1084. doi: 10.1073/pnas.41.12.1079. [DOI] [PMC free article] [PubMed] [Google Scholar]
SCHAPIRA G., DREYFUS J. C., SCHAPIRA F., KRUH J. Glycogenolytic enzymes in human progressive muscular dystrophy. Am J Phys Med. 1955 Feb;34(1):313–319. [PubMed] [Google Scholar]
SWINYARD C. A., DEAVER G. G., GREENSPAN L. Gradients of functional ability of importance in rehabilitation of patients with progressive muscular and neuromuscular diseases. Arch Phys Med Rehabil. 1957 Sep;38(9):574–579. [PubMed] [Google Scholar]
TYLER F. H., STEPHENS F. E. Studies in disorders of muscle. IV. The clinical manifestations and inheritance of childhood progressive muscular dystrophy. Ann Intern Med. 1951 Jul;35(1):169–185. doi: 10.7326/0003-4819-35-1-169. [DOI] [PubMed] [Google Scholar]
WALTON J. N., RACE R. R., PHILIP U. On the inheritance of muscular dystrophy; with a note on the blood groups, and a note on colour vision and linkage studies. Ann Hum Genet. 1955 Aug;20(1):1–38. doi: 10.1111/j.1469-1809.1955.tb01274.x. [DOI] [PubMed] [Google Scholar]
ZIERLER K. L. Aldolase leak from muscle of mice with hereditary muscular dystrophy. Bull Johns Hopkins Hosp. 1958 Jan;102(1):17–20. [PubMed] [Google Scholar]

ACTIONS

RESOURCES